Pamir Atagündüz

TL;DR: Early recognition and appropriate treatment of immunologic complications will decrease the morbidity and mortality in COVID-19 infection, which requires the collaboration of infectious disease, lung, and intensive care unit specialists with other experts such as immunologists, rheumatologists, and hematologists.

TL;DR: MEFV mutations, originally linked to FMF, may act as a genetic susceptibility factor for other inflammatory disorders such as vascular BD, and is investigated in patients from Turkey.

TL;DR: The findings suggest that cartilage-directed cellular autoimmunity might play an important role in joint-specific tissue damage in patients with AS and suggest an HLA-B27-restricted immune response.

TL;DR: Subclinical Achilles enthesitis, detected only with GS US, is present in a subset of AS patients and a significant improvement can be demonstrated after 2 months of TNF-alpha antagonist therapy.

TL;DR: The pathogenesis and the clinical picture of HLH, and its severe complication, the cytokine storm, is reviewed with a special emphasis on the developed classification criteria sets for rheumatologists, since COVID-19 infection has clinical symptoms resembling those of the common r heumatologic conditions and possibly triggers HLH.